article_metadata: Vivek Subbiah Robert E Brown Mary F McGuire Jamie Buryanek Filip Janku Anas Younes David Hong
article_metadata: 10.18632/oncotarget.1468
article_metadata: Oncotarget
article_metadata: 2014 Jan 15;5(1):95-102.
article_metadata: CC BY
article_metadata: https://pubmed.ncbi.nlm.nih.gov/24395633/
article_metadata: Antineoplastic Combined Chemotherapy Protocols / therapeutic use Hodgkin Disease / drug therapy
article_metadata: Antineoplastic Combined Chemotherapy Protocols / therapeutic use Hodgkin Disease / drug therapy Case Reports Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Adult Female Hodgkin Disease / immunology Hodgkin Disease / pathology Humans Hydroxamic Acids / administration & dosage Immunologic Factors / administration & dosage Molecular Targeted Therapy Phosphoinositide-3 Kinase Inhibitors Sirolimus / administration & dosage Sirolimus / analogs & derivatives TOR Serine-Threonine Kinases / antagonists & inhibitors Vorinostat Hydroxamic Acids Immunologic Factors Phosphoinositide-3 Kinase Inhibitors Vorinostat temsirolimus MTOR protein, human TOR Serine-Threonine Kinases Sirolimus
article_metadata: PMC3960191
article_metadata: 24395633
article_metadata: A novel immunomodulatory molecularly targeted strategy for refractory Hodgkin's lymphoma
article_metadata: 2014